Each year the JDCA reviews all T1D projects that are active in human trials to identify the ones that have the potential to become a Practical Cure. We focus our analysis on projects in human trials because this is a critical milestone for all research, and given the 10-14 years that are required to get through all stages of clinical testing, we believe projects in human trials offer the best chance of delivering a Practical Cure in the near future. 

In 2017, we reviewed 429 T1D projects that are currently in human trials. Only 11 of these projects are potential Practical Cure solutions, as shown in the chart below.